From With Atlas Cash and Berkeley Tools, Intellia Joins the CRISPR Fray:

Nessan Bermingham, CEO of Intellia and venture partner at Atlas Venture

Nessan Bermingham, CEO of Intellia and venture partner at Atlas Venture—

Nessan Bermingham, CEO of Intellia and venture partner at Atlas Venture

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

From Our Editors · Special Report
Xcelerating Life Sciences San Francisco: Special Report
The AI, Big Data, and R&D Boom

Sponsored · Whitepaper
Bridging the Diversity Gap with Decentralized Trials
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
PRA Health Sciences

Xconomy on Demand

We offer a number of ways to subscribe for free!